Arca Biopharma sell StockNews.com
Start price
24.02.24
/
50%
€1.51
Target price
24.02.25
-
Performance (%)
235.60%
Price
30.08.24
€2.22
Summary
This prediction is currently active. The SELL prediction by StockNews_com for Arca Biopharma is trending in the completely wrong direction and now has a performance of 235.60%. Dividends of €2.85 are taken into consideration when calculating the performance. This prediction currently runs until 24.02.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Arca Biopharma | -40.642% | -40.642% |
iShares Core DAX® | 1.560% | 2.566% |
iShares Nasdaq 100 | 0.517% | 1.894% |
iShares Nikkei 225® | 1.730% | 5.631% |
iShares S&P 500 | 1.482% | 1.594% |
Comments by StockNews_com for this prediction
In the thread Arca Biopharma diskutieren
ARCA biopharma, Inc. (NASDAQ: ABIO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ABIO provided by MarketBeat